Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-07-22 10:17 Tx date 2019-07-17 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$880,000
+200,000 vol $4.40 each |
600,000 | |
Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$200,000
+200,000 vol $1.00 each |
200,000 | |
Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$341,954
+337,900 vol $1.01 each |
387,900 | |
Filed 2018-10-09 Tx date 2018-10-04 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-64,569.60
-45,600 vol $1.42 each |
342,300 | |
Filed 2018-10-09 Tx date 2018-10-05 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$9,323
+7,301 vol $1.28 each |
349,601 | |
Filed 2018-10-09 Tx date 2018-10-05 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-5,709.74
-4,261 vol $1.34 each |
345,340 | |
Filed 2018-10-09 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-09-24 Tx date 2018-09-20 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,355,431.44
-291,115 vol $4.66 each |
||
Filed 2018-09-24 Tx date 2018-09-20 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,104,007.44
-237,115 vol $4.66 each |
400,000 | |
Filed 2018-09-23 Tx date 2018-09-20 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,355,431.44
-291,115 vol $4.66 each |
346,000 | |
Filed 2018-03-20 Tx date 2018-03-17 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
Filed 2018-01-11 Tx date 2018-01-05 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-340,122.505
-112,885 vol $3.01 each |
637,115 | |
Filed 2018-01-05 Tx date 2018-01-02 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-175,108.198
-71,854 vol $2.44 each |
948,146 | |
Filed 2018-01-05 Tx date 2018-01-05 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-475,550.40
-198,146 vol $2.40 each |
750,000 | |
Filed 2017-09-05 Tx date 2016-07-12 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-05 Tx date 2017-08-31 |
$ACST
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,000
+50,000 vol $1.60 each |
50,000 | |
Filed 2017-08-22 Tx date 2017-08-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,468
+26,778 vol $0.88 each |
180,454 | |
Filed 2017-08-22 Tx date 2017-08-18 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,587
+22,276 vol $0.88 each |
153,676 | |
Filed 2016-09-16 Tx date 2016-09-14 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-246,645.176
-101,680 vol $2.43 each |
50,000 | |
Filed 2016-08-04 Tx date 2016-08-03 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-157.00
-100 vol $1.57 each |
151,680 | |
Filed 2016-08-03 Tx date 2016-08-02 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-3,206.95
-2,069 vol $1.55 each |
151,780 | |
Filed 2016-08-01 Tx date 2016-07-28 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-310.00
-200 vol $1.55 each |
153,849 | |
Filed 2016-07-26 Tx date 2016-07-25 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-477.00
-300 vol $1.59 each |
154,049 | |
Filed 2016-07-22 Tx date 2016-07-20 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-150.00
-100 vol $1.50 each |
154,349 | |
Filed 2016-07-19 Tx date 2016-07-12 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-07-19 Tx date 2016-07-14 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-36,617.895
-23,550 vol $1.55 each |
||
Filed 2016-07-19 Tx date 2016-07-14 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-36,617.895
-23,550 vol $1.55 each |
154,450 | |
Filed 2016-07-19 Tx date 2016-07-15 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-1.60
-1 vol $1.60 each |
||
Filed 2016-07-19 Tx date 2016-07-15 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-1.60
-1 vol $1.60 each |
154,449 | |
Filed 2016-07-19 Tx date 2016-07-12 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
178,000 | ||
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,020,000 | ||
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-07-18 Tx date 2016-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+75,000 vol $1.24 each |
75,000 | |
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
131,400 | ||
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Schottenfeld Associates LP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,757,086 | ||
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-07-18 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-07-13 Tx date 2016-07-12 |
$APO
Acasti Pharma Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
235,906 | ||
Filed 2016-07-13 Tx date 2016-07-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,159,896 |